Shaanxi Panlong Pharmaceutical Group Co., Ltd. researches and develops, produces, and sells Chinese patent medicines and traditional Chinese medicine formula gr...
The A-shares opened lower and rose higher, with all three major indices turning positive. The chemical and electric grid sectors collectively surged, the Hang Seng Index fell over 1%, tech stocks continued to decline, and Shanghai silver dropped over 13%
Chinese medicine stocks opened sharply higher, with Panlong Pharmaceutical and TY PHAR. hitting the daily limit, and Bio Valley and LSPG rising over 10%
The three major A-share indices of Shanghai and Shenzhen opened lower by 0.9% to 1.2%, with oil and gold stocks weak, while traditional Chinese medicine stocks rose against the trend
Zhitong A-share lock-up release overview | November 4
Panlong Pharmaceutical: The net profit for the third quarter was 29.6707 million yuan, a decrease of 0.83%
Panlong Pharmaceutical: The company currently has no overseas sales business